Best of the Week: November 21 – November 27, 2025 | Cannabis Science and Technology

Let’s dive into the high tales shaping the dialog this week. Summaries of every article are listed beneath.

In the hashish trade, the day earlier than Thanksgiving is referred as the greatest gross sales day of the 12 months. The vacation occasion known as “Green Wednesday” and can higher be often known as the “Black Friday” for hashish.

To have a good time, Cannabis Science and Technology put the highlight on hashish by compiling green-related content material, new and outdated. From product manufacturing of edibles, topicals, and pre-rolls to different hashish science, the hashish plant is an interesting topic that Cannabis Science and Technology is devoted to masking intently.

The verdict is in on hemp in Ohio. After going by the House and Senate in the Buckeye State, Senate Bill 56 (SB 56) was sent to a legislative conference committee where members voted to approve, as well as advance a “negotiated” version of the bill. The new model brings new updates to the voter-approved adult-use hashish legalization laws.

Senate Bill 56 would restrict the sale of some hemp-derived merchandise in order that they will solely be bought from state-licensed dispensaries, set up a path for people who’re concerned with expunging prior cannabis-related convictions, specify that adults can devour hashish legally inside their non-public property, in addition to redirect a portion of tax revenues stemming from hashish transactions that may go to particular person municipalities that license hashish retailers.

On November 24, 2025, the US Hemp Roundtable issued a press launch concerning the action points needed for the hemp industry following the passage of the FY26 Agriculture Appropriations Bill.

“Our first priority is to secure an additional one-year moratorium on the effective date of the ban,” the press launch states. “We’ve seen a strong public backlash, with many more Members of Congress raising their voices in favor of regulation, not prohibition. This additional one-year period would allow for the appropriate level of transparency and scrutiny needed to reach a responsible resolution.”

The November installment of the month-to-month Healer webinars, hosted by Dustin Sulak, DO, lined a number of revealed research on hashish for numerous situations together with diabetic neuropathy, persistent again ache, and opioid induced persistent apnea. The webinar also covered recent research in cannabinoids and Alzheimer’s disease symptoms.

Researchers in Israel explored hashish plant terpenes, discovering that in a dose-dependent method, that cannabis plant terpenes were activating endogenous cannabinoid receptors. Preclinical knowledge was revealed in the journal, Biochemical Pharmacology. Study organizers evaluated the modularity capacity of 16 terpenes from the hashish plant which included α-pinene, β-pinene, limonene, myrcene, ocimene, sabinene, terpinolene, borneol, eucalyptol, geraniol, linalool, terpineol, β-caryophyllene, humulene, bisabolol, and nerolidol.

“This study provides evidence suggesting that multiple cannabis-derived terpenes, when tested in the absence of cannabinoids, act as partial agonists at CB1R and CB2R, with significant variability in apparent potency, efficacy, and receptor selectivity,” the examine’s authors defined. “Collectively, these findings suggest a pharmacological basis for incorporating specific terpenes into ECS-focused product design and warrant further research into their tissue-specific activity, and synergistic potential when used in combination with cannabinoids or other therapeutic agents.”